North America Tissue Expander Market

North America Tissue Expander Market Size (2022 to 2027)

The size of the North America Tissue expander Market was valued at 437.24 million in 2022. The current market trend is expected to reach 760.30 million by 2027, rising at a CAGR of 11.7% from 2022 to 2027.

According to the American Society of Plastic Surgeons, the highest number of reconstructive surgeries was implemented in the United States. The surging incidence of breast cancer in the U.S and Canada is expected to enlarge the market growth. Escalating healthcare demand, technological advancements, and rising consciousness related to tissue widening are propelling the need for this market. According to the American Society of Plastic Surgeons, nearly 102,250 breast construction procedures were implemented, which depicts an increase of 7% from last year, in 2014. Approximately 15,700 people are suffering from burns in the United States, according to U.S fire Administration (USFA), in 2015, where accidents can lead to critical lower and upper extremities along with scars and effects. Several people choose treatment processes like lumpectomy and mastectomy, one of the major factors bolstering the tissue expander market growth in North America.

The increased costs associated with the overall treatment is the key factor in restricting market growth. Side-affects related to the treatment and shortage of experienced medical staff and professionals are hindering the market growth. Inadequate reimbursement policies are limiting growth.

The North American Tissue Expander Market has been segmented & sub-segmented into the following categories:

• By Application: Breast Reconstruction (Single-stage breast reconstruction and Two-stage breast reconstruction), Forehead skin and scalp reconstruction, Neck and face reconstruction
• By Shape: Anatomical, Round, Rectangular, and Crescent
• By End Use: Hospitals, Cosmetology Clinics, and Ambulatory Surgical Centres
• By Country: The United States, Canada, and Rest of North America

Regional Analysis:

The North America rate is expected to dominate during the period. It is predicted to enlarge the growth faster due to well-developed healthcare systems and appropriate reimbursement schemes. U.S and Canada are the major contributors to the tissue expander market in this region.

The U.S is dominating the tissue expander market because of the highest number of reconstructive surgeries incorporated with a growing number of cases of cosmetic surgery procedures propelling the tissue expander market. Growth in the number of road accidents and burns can produce defects and problematic scarring, requiring surgical assistance and therapy. 1 in every 33 newborn babies in the U.S. is affected by a congenital disability, according to the Centers for Disease Control and Prevention (CDC). Moreover, increasing healthcare expenses and the extensive spread of different congenital diseases add fuel to the market growth during the analysis period.

The Canadian market is anticipated to have quick growth to produce profitable results at a brisk rate during the analysis period. 

Some of the key manufacturers in the North America tissue expander market analyzed in this report are PMT Corporation, Allergan, Sientra Inc, GROUPE SEBBN SAS, Guangzhou Wanhe Plastic Materials Co. Ltd, KOKEN CO. LTD, Mentor Worldwide LLC, Eurosilicone, Speciality Surgical Products, AirXpanders, Nagor, Laboratories Arlon, Polytech Health.